Bangalore-based biotech firm Biocon's independent director, Neville C Bain has sold shares of the company aggregating to Rs 4.23 crore, through open market transactions.
In two separate transactions, Bain has sold 125,000 shares and 50,000 shares of the biotechnology firm, for Rs 2.99 crore and Rs 1.23 crore, respectively, Biocon said in a disclosure to the Bombay Stock Exchange.
Bain held 0.5 per cent stake in Biocon, and after the two transactions his holding has come down to 0.4125 per cent or 825,000 shares.
Shares of Biocon were trading at Rs 253.30 on the BSE, up 0.66 per cent from its previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app